ArticlePloS one2025
Business sustainability of medicinal plant production under risk in the northwest region of Bangladesh: A simulation analysis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medicinal plants (MP) provide an opportunity for profitable farming, agricultural diversification, and sustainable livelihoods in Bangladesh. This study aims to examine the business sustainability of MP production under risks, i.e., price, yield and market absorption. Data were collected from 196 individual farms that cultivate Aloe vera (L), Bombax ceiba (L) root, and Withania somnifera (L). The business viability analysis was carried out by evaluating the net present value (NPV), internal rate of return (IRR), benefit-cost ratio (BCR), return on investment (ROI), and real option value (ROV) of selected MP. The results indicated that the NPV was positive, the BCR was greater than 1, and the IRR exceeded the prevailing bank rate. It also found that the production of MP faces three major risks: pricing, yield, and market absorption. The simulation analysis's findings indicated that MP producers will eventually experience losses with embedded risks. On the other hand, the ROV finding indicated that NPV increases with option value over time. Farmers may receive profit from their investments in A. vera, B. ceiba root, and W. somnifera, and their farming business will eventually become sustainable in the long run. Thus, farmers should plan for producing MP in the long run and policy should be triggered on tackling risk reduction strategies through introducing marketing contract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.